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a b s t r a c t 
Combating necrosis, by supplying nutrients and removing waste, presents the major challenge for en- 
gineering large three-dimensional (3D) tissues. Previous elegant work used 3D printing with carbohy- 
drate glass as a cytocompatible sacrificial template to create complex engineered tissues with vascular 
networks (Miller et al. 2012, Nature Materials). The fragile nature of this material compounded with 
the technical complexity needed to create high-resolution structures led us to create a flexible sugar- 
protein composite, termed Gelatin-sucrose matrix (GSM), to achieve a more robust and applicable mate- 
rial. Here we developed a low-range (25–37 ̊C) temperature sensitive formulation that can be moulded 
with micron-resolution features or cast during 3D printing to produce complex flexible filament net- 
works forming sacrificial vessels. Using the temperature-sensitivity, we could control filament degener- 
ation meaning GSM can be used with a variety of matrices and crosslinking strategies. Furthermore by 
incorporation of biocompatible crosslinkers into GSM directly, we could create thin endothelialized vessel 
walls and generate patterned tissues containing multiple matrices and cell-types. We also demonstrated 
that perfused vascular channels sustain metabolic function of a variety of cell-types including primary 
human cells. Importantly, we were able to construct vascularized human noses which otherwise would 
have been necrotic. Our material can now be exploited to create human-scale tissues for regenerative 
medicine applications. 
Statement of Significance 
Authentic and engineered tissues have demands for mass transport, exchanging nutrients and oxygen, and 
therefore require vascularization to retain viability and inhibit necrosis. Basic vascular networks must be 
included within engineered tissues intrinsically. Yet, this has been unachievable in physiologically-sized 
constructs with tissue-like cell densities until recently. Sacrificial moulding is an alternative in which 
networks of rigid lattices of filaments are created to prevent subsequent matrix ingress. Our study de- 
scribes a biocompatible sacrificial sugar-protein formulation; GSM, made from mixtures of inexpensive 
and readily available bio-grade materials. GSM can be cast/moulded or bioprinted as sacrificial filaments 
that can rapidly dissolve in an aqueous environment temperature-sensitively. GSM material can be used 
to engineer viable and vascularized human-scale tissues for regenerative medicine applications. 
© 2020 Acta Materialia Inc. Published by Elsevier Ltd. 
This is an open access article under the CC BY license. ( http://creativecommons.org/licenses/by/4.0/ ) 
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Native tissues have high demands for mass transport exchang-
ng nutrients and oxygen for metabolic waste [1 , 2] . As tissue de-
elops these requirements are met primarily by blood perfusion
hrough large multi-centimetre to multi-micron scale vessel net-rticle under the CC BY license. ( http://creativecommons.org/licenses/by/4.0/ ) 





















































































































works [3] . All tissues and organs require some vascularization and
this developmental angiogenic process was critical to the evolution
of higher organisms [4] . When fabricating tissue for regenerative
medicine applications this network must be included intrinsically
within the tissue matrix and even basic vascular networks in sim-
ple physiologically-sized constructs with tissue-like cell densities
have been unachievable until recently [5] . 
Various approaches have been developed to create perfusable
vascularized tissues including layer-by-layer assembly [6–8] and
recently complex additive manufacturing/3D printing/Bio-printing
technologies [1 , 2 , 9] . Layer-by-layer technologies (which moulds a
channel into one layer such that bonding of the second flat layer
creates a vessel [7] ) is an iterative process and can create thick,
multi-layered tissues. However fabrication is slow and creates
layer-to-layer seams and other structural artefacts [9] . There are
also considerable design constraints on materials, channel design
and cells during assembly [10] . Bioprinting using cells, matrix or
both which are deposited drop-wise [9] is also relatively slow, and
a serial additive process with limitations on resolution. Further-
more both technologies require direct addition of cells to the man-
ufacturing process from the initial printed [11] or bonded layer
[9] meaning that conditions need to be controlled to maintain en-
vironmental biocompatibility such as temperature, pH, humidity,
nutrients and sterility [3] . 
Sacrificial moulding is an alternative approach in which chan-
nel networks are fabricated by creating rigid lattices of filaments
which are used to prevent subsequent matrix ingress. These struc-
tures are cast inside a matrix containing cells, and post-casting re-
moval of this material reveals a microfluidic vasculature in the bulk
matrix. This work has been previously inhibited by the use of cyto-
toxic organic solvents, or harsh environmental conditions to create
or remove the sacrificial filaments, or when casting/crosslinking
the bulk surrounding matrix [6 , 12] . An elegant report demon-
strated that this approach could be achieved using aqueous-based
materials and protein-based biological matrices for the bulk ma-
terial and can be used with living cells [5] . This technology used
carbohydrate-dextran glass 3D printing to create a sugar sacrificial
lattice. In another recent study, more designs with smaller diame-
ter channels and smoother in-plane junctions were achieved [13] .
The approach, though requiring much optimization to achieve the
resolution and accuracy during fabrication, allowed perfused vas-
cular channels to be created in thick constructs and maintained
metabolic function of cells in the engineered tissue [5] . 
Here we describe a biocompatible sacrificial material, called
GSM, which has properties beyond that of carbohydrate-dextran
glass. A simple sugar-protein formulation made from mixtures of
inexpensive and readily available bio-grade materials can be used
to cast/mould or bio-print structures as sacrificial filaments in or-
der to facilitate fabrication of 3D vascular networks in engineered
tissues. We created a material with sufficient mechanical stiffness
to support its own weight in the architecture designed and also the
ability to rapidly dissolve in an aqueous environment temperature-
sensitively. These properties mean that GSM is biocompatible with
cells and allows the use of any synthetic or natural matrix or
crosslinking strategy. Importantly GSM material can now be used
to engineer human-scale tissues with functioning vascular net-
works. 
2. Materials and methods 
2.1. Materials & cell maintenance 
Materials were purchased from Sigma-Aldrich (Dorset, UK)
unless stated otherwise. NIH3T3 mouse embryonic fibroblasts
(NIH3T3s), human umbilical vein endothelial cells (HUVECs), BJ6
fibroblast cells and HepG2 cells were obtained from the LGC Stan-ards (Middlesex, UK). HUVEC media was supplied by Promocell
Heidelberg, Germany). immortalized human mesenchymal stem
ells (iHMSCs) were created in-house as described previously [14] .
MEM media and rat tail collagen I were obtained from Invitrogen
ife Technologies (Paisley, UK). Lentiviral labelling of cell lines was
erformed as described previously [15] . Cells were infected with
nhanced green fluorescent protein (GFP)- or monomeric red flu-
rescent protein (mRFP)-labelled lentivirus at confluence and se-
ected with puromycin for 7 days which produced > 95% labelled
ells confirmed by flow cytometry. Cells were cultured in isola-
ion at 37 °C in a 5% CO 2 incubator. NIH3T3, HEK293T, HepG2,
HMSCs and BJ6 cells were maintained in DMEM media contain-
ng 10% ( v/v ) FCS and 1% penicillin/streptomycin. HUVEC cells were
aintained in endothelial cell growth media supplemented with
.02% (v/v) FCS, 0.004% (v/v) endothelial cell growth supplement,
.1ng/ml epidermal growth factor, 1ng/ml basic fibroblast growth
actor, 90 μg/ml heparin, 4 μg/ml hydrocortisone, and 1% peni-
illin/streptomycin. 
.2. ESM and GSM preparation 
Commercially available SugarVeil TM (SugarVeil TM Products
orporation) or biological grade reformulated ESM [Sucrose
Silksugar TM , British Sugar); 43.7% w/v, Egg white protein (EWP;
igma E0500); 4.85% w/v, Starch (Miragel TM 463); 0.26% w/v,
anthan Gum (Sigma G1253); 0.26% w/v, Maltodextrin (Sigma
19699); 0.87% w/v, final concentrations] was reconstituted ac-
ording to commercial product patent details using dH 2 O [16] .
SM was formulated replacing EWP with the same concentration
48.5mg/ml) porcine skin gelatin (Sigma G1890). GSM required in-
ubating overnight at 60 ̊C to complete dissolve the gelatin was
laced at 37 ̊C prior to casting or printing. 
.3. Matrices and cell encapsulation 
Gelatin methacrylate (GelMA) was synthesized as previously
escribed [17] . GelMA (20% w/v final concentration) was dissolved
n PBS containing photoinitiator dissolved at 60 ̊C (Irgacure 2959;
.05% w/v final concentration). Cells of interest (0.1-5 × 10 7 /ml)
ere mixed in minimal volume with the GelMA solution and dis-
ensed into 4 × 12mm moulds (500 μl total volume) with or
ithout GSM structures. GelMA structures were photopolymerized
Omnicure 20 0 0, 320-50 0 nm) at 20 0mW/cm 2 for 30 s. Fibrin gels
20mg/ml) were created by addition of thrombin (200U/ml) to fib-
inogen (20mg/ml) in PBS containing the cell suspension and dis-
ensing around the GSM structure. Matrigel TM gels were formed by
ixing loose cell pellets with Matrigel TM on ice, dispensing around
he GSM structure, followed by 20min incubation at 37 ̊C. Alginate
els (2% w/v) were prepared using a slow setting formulation pre-
iously described [18] . Agarose gels (2% w/v) were formed by mix-
ng ultra-low-gelling temperature agarose (Type IX, Sigma A5030,
t 40 ̊C) with loose cell pellets and placing for 10min at 4 ̊C. Colla-
en type-I gels (2mg/ml, rat tail tip, BD-biosciences) were formed
s previously described requiring 30min at 37 ̊C for complete gela-
ion [18] . After crosslinking all hydrogels were placed in complete
ell media (for each respective cell type) ensuring that open ves-
el faces were exposed to the media and placed at 37 ̊C. After 15
in, the culture media was replaced, and constructs were cultured
nder standard conditions. For perfusion, a peristaltic pump was
onnected to a bespoke chamber and flow rate set to 600μl/min.
or 800μm constructs, these generated velocities of 2-8mm/s and
 shear stress of 0.5-2 dyn/cm 2 , which are physiologically relevant
alues. 





















































































































.4. Diffusion and secretion from vasculature 
Diffusion studies used FITC- and Rhodamine-labelled Dextran (4
nd 70kDa, respectively, 1mg/ml) as previously described [19] . La-
elled media was injected into a single engineered vessel lumen
nd fluorescence measured in 6 well plate format on an Infinite
200 plate reader (Tecan). 
Lentiviral reporter constructs were generated as previously de-
cribed [15 , 20] . IgH-mRFP was cloned into pSIN-PURO by PCR
nd HepG2 cells infected at a multiplicity of infection (MOI) of
0 and selected with puromycin for 2 weeks. IgH-mRFP release
as measured by fluorometry using an Infinite M200 plate reader
Tecan). Albumin in sampled media was quantified by enzyme-
inked immunosorbent assay (ELISA) using a human albumin ELISA
it (Bethyl labs). Urea in sampled media was measured by acid-
nd heat-catalysed condensation of urea with diacetylmonoxime to
ive a coloured-product that was measured spectrophotometrically
Urea Nitrogen kit; StanBio Labs). 
.5. PCL and GSM casting and printing 
Commercially available silicon lace mats (SugarVeil TM Products
orporation) or bespoke silicon mats were used to cast/mould ESM
r GSM into 2D patterns using manufacturer’s guidance notes.
aterial was left at room temperature for > 6h to achieve struc-
urally sound matting when extracted from moulds. GSM printing
sed heated syringes (at 60 ̊C) on a 3D Discovery® bioprinter (Re-
enHU). PCL (M n = 40,0 0 0 - 50,0 0 0 g/mol; Sigma-Aldrich, UK) was
rinted at 77 °C using a precision extrusion deposition system as
escribed in [21] . The material was extruded through a 23 gauge
ozzle (0.33mm) steel nozzle. The printing parameters were set as:
rint-head travelling rate of 16 mm/s, pressure of the PCL melt
hamber was 4 bar and feeder extrude rate was 20 revolutions
er meter. Between PCL layers GSM was either printed (through
 21 gauge plastic tip) or applied and cast as for 2D fabrication.
fter fabrication PCL/ GSM composite structures were dried for
 6h in a 37 ̊C oven, frozen at -80 ̊C and freeze-dried for 2 days.
o remove the PCL scaffolds were then immersed in chloroform at
oom-temperature until all PCL was dissolved (10min-6h). Struc-
ures were washed twice in fresh chloroform and allowed to dry
nder laminar flow for 30min. GSM networks were either used
irectly with cells or were stored vacuum sealed or at 37 ̊C to
revent moisture absorption. For Wax moulding of GSM, we used
 ProJet TM CPX 30 0 0 plus (3DSYSTEMS) 3D printing according to
anufactures instructions. Vessels to be filled with GSM were ini-
ially printed with VisiJet® S200 support material (3DSYSTEMS)
hich is isopropanol soluble and was removed by isopropanol
athing ready for GSM injection. 
.6. Construct visualization 
Pre-casting images were captured by a Nikon SMZ 1500 micro-
cope with a SPOT insight camera, or a Nikon Eclipse TS100 Micro-
cope (Nikon Instruments, Surrey, UK). To view 3D constructs a TCS
SI super zoom confocal microscope was used (Leica Microsystems,
ilton Keynes, UK). 
.7. Data and statistical analysis 
Data are presented for cells cultured on at least three separate
ccasions and are expressed as mean ± SEM. Data were analysed
GraphPad Prism, San Diego CA) using unpaired T-test. . Results 
.1. Assessment of sugar-protein sacrificial material, ESM 
Protein-sugar materials can be formed by dissolving a proteina-
eous material with a thickening agent and sucrose into water.
e initially investigated the use of a commercially available con-
ectionary product (SugarVeil TM ; [16] ) as a potential candidate as
 base for material development. For translation into an experi-
ental and biomedical context, we reformulated it using biologi-
al grade reagents. The matrix contains egg white protein (EWP;
f which ovalbumin is the main constituent [22] ) as the proteina-
eous component and the material is created by addition of boil-
ng ( > 95 °C) distilled water and mixing (40 rpm for 5 min) which
chieves the flowable protein-foam. We termed our reformulated
aterial EWP-sucrose matrix (ESM). The ESM foam has a pH value
f 7.2, at low density (0.4g/ml) and has sufficient viscosity (~75,0 0 0
P) to allow low aperture printing but accuracy at high-resolution
 > 50μm filament diameter) [16] . The hygroscopic properties of
SM were advantageous as when dried then humidified, it pos-
esses up to 50% elasticity meaning that it is not as brittle as sim-
le carbohydrate glasses. This transition is reversible as at ‘room’
elative humidity (RH; 30% RH), it dries to form a hard and brittle
aterial; however placing for 5 min at 95% RH (on a release sub-
trate such as silicon) it softens recreating the mouldable, flexible
nd stretchable material. 
Uniaxial compression testing of ESM in 95% RH or partially
ydrated (30% RH) conditions showed elastomeric and stiff me-
hanics, respectively. Importantly when ESM was completely de-
ydrated it is significantly stronger than carbohydrate-only or dex-
ran containing formulations [16] . 
.2. ESM as a biocompatible sacrificial material 
For ESM to be employed sacrificially it must dissolve quickly
n supersaturated conditions and diffuse away rapidly leaving
ts previous space completely vacant for diffusion and perfusion.
e tested the dissolution kinetics of ESM in comparison to the
arbohydrate-dextran blend used in a previous study [5] . We
emonstrated that the half-dissolution time for ESM was 43 ±7 and
1 ±4 s at 25 ̊C and 37 ̊C, respectively, which is slower but com-
arable to carbohydrate-dextran kinetics (9 ±3 s). We noted that
ome material from ESM did not fully dissolve even with pro-
onged incubation ( Fig. 1 ). Centrifugation (at 15k x g) revealed ap-
roximately 3.1 ±0.2% of ESM mass (6.2 ±0.4% of the dry mass) was
nsoluble after dissolution ( Fig. 1 C). We determined that the ma-
ority of insoluble mass was attributable to denatured EWP [23] as
ormulations lacking EWP had 0.30 ±0.09% insoluble mass. Next,
e assessed its biocompatibility by incubating solutions of dis-
olved ESM with immortalized human mesenchymal stem cells
iHMSCs) and assessing viability and proliferation over a 12h cul-
ure period (Fig. S1A). This is important as the sugar-content does
ot osmotically damage living cells. Even at concentrations of 20%
/v (0.2g/ml), there was no significant effect on proliferation (dou-
ling times of 21 ±2h at day 3 versus 19.3 ±1.3h for controls) nor
iability (95 ±3 viability at day 3 versus 97 ±3 for controls) com-
ared to controls. 
It is important that any sacrificial material is compatible with
he use of matrices crosslinked by photochemical reactions [24] .
nlike carbohydrate or carbohydrate-dextran blends, ESM is not
ompletely optically transparent (as a constituent is starch-based
nd contains denatured EWP). However, its absorption properties
ndicated it did transmit significantly at wavelengths compatible
ith photopolymerization [25] including UV, visible and near IR
anges (Fig. S2). 
342 H.M. Eltaher, F.E. Abukunna and L. Ruiz-Cantu et al. / Acta Biomaterialia 113 (2020) 339–349 
Fig. 1. Reformulation of ESM into temperature-sensitive GSM. Fig. 1. Formulation of ESM into temperature-sensitive GSM. The reformulated ESM material using biological 
grade chemical was modified to contain gelatin rather than EWP to confer temperature-sensitive properties to the material, termed GSM. ( A-B) Examination of the dissolution 
processes of ESM and GSM. Scientific-grade ESM and GSM formulations were tested in the same conditions as in (A) but PBS was sampled and tested for sucrose (sugar 
component of both materials); ( A) and protein (EWP or gelatin components of ESM and GSM, respectively; ( B) release using sucrose and BCA assays, respectively. Sugar 
dissolution was rapid (full by ~4 min.) for both materials except for GSM at 25 °C which was complete after ~2 h) post-hydration with PBS. Protein dissolution was similar 
with all protein dissolved within 4 min (~5 min. for GSM at 37 °C) except for GSM at 25 °C which was never fully dissolved even after long incubations (32 h only ~50% 
dissolved) with the overall structure remaining intact. ( C) Estimation of the insoluble material after full dissolution of ESM (Mix plus EWP, GSM (Mix plus Gelatin) or using 
BSA as the protein element (Mix with BSA; BSM). Material was incubated in excess PBS (1g material in 10ml PBS) for 48 h at 37 °C, centrifuged (20,0 0 0 x g) and the pelleted 
material dried and compared to the original mass. EWP in ESM leaves a significant insoluble fraction (~3% w/w) whereas BSA and Gelatin leave no further insoluble material 
over the mix alone (~0.4% w/w). Importantly these formulations when fully dissolved could be passed through 0.4μm disc filtered demonstrating that any residual insoluble 
material was smaller than this pore size. ( D) The protein content of ESM and GSM is stable even after multiple chloroform extractions. ( E) GSM (50mg/ml) was cast by a 
silicone-mould screening technique into mesh pattern and tested for temperature sensitivity by addition of PBS at 25 °C or 37 °C. After 10 min static incubation at 37 °C the 
mesh was fully dissolved, at 25 °C the material retained its structure. Bar is 2 mm. ∗ p < 0.05. 

































































































































t  .3. Reformulation to create temperature-sensitive GSM 
A major drawback of carbohydrate-dextran blends described in
 previous study is its lack of stability during casting and crosslink-
ng of the bulk matrix surrounding it [5] . The authors of that study
oated fabricated lattices with poly(lactic-co-glycolic) acid (PLGA)
issolved in chloroform to improve its stability, allowing it to pre-
ent matrix ingress sufficiently long to retain the sacrificial struc-
ure on dissolution. Slow setting hydrogels such as collagen type-I
~30 min to set) which rely on fibrillogenesis by strand precipita-
ion with a pH change [26] , are problematic with the carbohydrate-
extran system and were not tested in the previous study [5] . ESM
lso performs poorly if the encasing matrix is slowly crosslinking,
o we reformulated the material removing EWP and replacing with
ovine serum albumin (BSA; termed BSA-sucrose matrix or BSM)
r porcine skin gelatin (gelatin; termed gelatin-sucrose matrix or
SM) or blends of both ( Fig. 1 A–C). Gelatin is a temperature re-
ponsive protein [27] which gels at sufficiently high concentrations
t < 32 ̊C. Removing EWP led to a higher density material (i.e. less
oaming) and removed the majority of insoluble material remain-
ng after dissolution ( Fig. 1 C, 0.28 ±0.07% for complete replace-
ent with gelatin). Importantly, increasing amounts of gelatin im-
roved the retention of volume upon superhydration (submerging
n dH 2 O) at temperatures < 32 ̊C. Concentrations > 30mg/ml gelatin
ere sufficient to retain the structure which converted from a stiff
rittle material into a soft hydrogel upon complete hydration. We
ontinued study of the material entirely proteinated with gelatin
48.5mg/ml), Gelatin-sucrose matrix (GSM), as it retained the best
emperature-responsive properties and still dissolved rapidly when
laced at permissive ( > 32 ̊C) temperatures ( Fig. 1 A and B; 9 ±2 h
erses 35 ±6 s at 25 ̊C and 37 ̊C, respectively). 
We empirically determined a GSM concentration (60% w/v in
H 2 O) that yielded a final hydrated composition which flows read-
ly through extremely small apertures (30 gauge; 159μm) when
eated > 32 ̊C and thus can be formed into detailed and complex
atterns (extruded filament diameter of 100μm). GSM is more op-
ically transparent than ESM either at 25 °C or 37 °C and this there-
ore compatible with photoactive fabrication strategies (Fig. S2). 
.4. Multiscale vascular networks of GSM 
We initially investigated 2D fabrication of GSM patterned sheets
 Fig. 1 , S3). GSM can be simply extruded on a release substrate
silicon sheeting) or can be silk screen moulded [28] into complex
atterned vascular sheets which can be easily dissolved ( Fig. 1 E,
3). Importantly the rapidity of GSM removal was retained when
ncased in hydrogels meaning that the high sugar concentration
f GSM would have minimal effect on cell viability. The sugar
lement rapidly hydrated and at 37 °C gelatin quickly liquefied
 < 1min) and flowed from vessels even in complex structures. Prior
o use these sheets can be stored for several weeks and, if required,
an be softened or hardened by varying humidity before further
abrication. Furthermore, these 2D patterns can be combined and
onded with addition and dehydration of more GSM to create in-
nite possible vessel configurations before bulk material fabrica-
ion. GSM sheets may also be rolled into vessels creating tubular
tructures with vascularized walls (Fig. S4). This is an interesting
pplication which does not require bioplotting but can manually
enerate vascularized sheets or tubes. 
Unlike carbohydrate-dextran glass [5] , GSM is not completely
elf-supporting due to its moisture content before gelation of its
elatin component. However, when dehydrated/lyophilized, GSM is
n exceptionally durable material. Therefore, for direct use in 3D
abrication we optimized the printing conditions (methods) and in-
estigated co-fabrication materials, which allowed rapid fabrication
ithout the need to regulate humidity of room-temperature. Manytudies using thermal extrusion additive manufacturing technolo-
ies have employed polycaprolactone (PCL) as a printable bioma-
erial or as a scaffold for weaker or uncrosslinked materials such
s hydrogel matrices [21 , 29] . Importantly, PCL is chloroform solu-
le [30] , whereas all of the constituents of GSM are not ( Fig. 1 D).
herefore, extraction of PCL from co-engineered constructs could
e achieved easily by bathing in chloroform (2–12h at room tem-
erature). If instantaneous stronger mechanical properties were
mmediately required beyond that of the hydrogel used, then the
CL could be left as seen in other strategies [21] . Chloroform has
een used as a method to sterilize biomass [31] and collagen hy-
rogels [32] for decades. Therefore this chloroform step could be
sed in all applications to remove bacterial and viral load of good
anufacture practice (GMP) materials to generate GSM for transla-
ion. To demonstrate the approach we employed extrusion of PCL
o create layer-by-layer moulds for GSM to be cast or extruded into
uring fabrication [21] (Fig. S5). This approach allowed the physical
roperties of PCL to be employed to create 3D moulds of complex
rchitecture with GSM embedded in each layer forming the ves-
el structures. Between layers both PCL and GSM fused creating a
ontinuous structure and layer intersections. After chloroform ex-
raction of PCL the GSM structure was revealed as an inverse of
he printed PCL and layers remained fused and mechanically sound
Fig. S5). We have also demonstrated this chloroform-dissolvable
caffold approach using wax-based scaffolds and a commercial
rinting system (ProJet TM CPX 30 0 0 plus; 3DSYSTEMS) which can
chieve structures of 10μm resolution over 50mm scales (Fig. S6).
e found that fully extracted GSM structures could represent
 85% accuracy when compared to the original 3D model file used
or fabrication using μCT analyses. 
We initially aimed to demonstrate a simple lattice structure as
 sacrificial element for creating fluidic channels within monolithic
ell-laden constructs. For this a cell suspension of non-crosslinked
lginate matrix is cast around the GSM construct to encapsulate
he architecture. After matrix crosslinking, the temperature is in-
reased to 37 ̊C to dissolve the GSM lattice and form intercon-
ected vessels. For carbohydrate-dextran lattices [25] , this process
equired PLGA coating of the structure in chloroform before cast-
ng of hydrogels with cells. We saw rapid release of some GSM
omponents into the cast matrix except for the gelatin component
hich retained the lattice architecture during matrix crosslink-
ng (as demonstrated in Fig. 1 A & B). As we previously demon-
trated for ESM, GSM does not elicit osmotic damage to cells (10%
/v leaves 95.7% viability over 24h in iHMSC cells: Fig. S1) due
o the rapid removal of the material after casting. Furthermore,
he temperature-sensitive GSM structure was stable in superhy-
rated conditions at lower temperatures (unlike carbohydrate-
extran glass) and no disruption to matrix crosslinking during dis-
olution was observed meaning we did not need to employ the
reviously described PLGA-coating approach [25] . Analyses in sim-
le lattices of the distribution of the carbohydrate- and gelatin-
onstituents of GSM revealed that 78 ±11% and 95 ±5%, was flowed
ut of the formed channels rather than through the bulk construct,
espectively. Our approach retained a vessel surface property that
llowed unrestricted diffusion from vessels into the bulk gel (Fig.
7B and C). 
To demonstrate the generic application of GSM to vessel fabri-
ation, we patterned vascular channels with casting of cells sus-
ended in a wide range of matrices, including those with di-
erse crosslinking mechanisms and slow crosslinking kinetics such
s for type-I collagen (Fig. S7). The time taken for the full cell-
ncapsulation process is dependent entirely on the crosslinking
ethod and GSM removal at 37 ̊C depending on construct ar-
hitecture is complete in 10–30min. Also trapped air within hy-
rogels can be evident depending on the nature of the applica-
ion, however this can be removed by centrifugation. We demon-

























































































































T  strated the approaches of chain entanglement (Agarose), ionic
crosslinking (Alginate), photopolymerization (Gelatin methacrylate;
GelMA), enzymatic crosslinking (Fibrinogen cleaved by thrombin)
and protein precipitation either completed in rapid (Matrigel TM )
or slow crosslinking (Rat tail Collagen Type-I). GelMA constructs
crosslinked by photochemical means did not show artefacts in
gelation due to shadowing; demonstrating low light absorption by
the GSM (Fig. S2). 
We assessed the direct effect on cell encapsulation with the
GSM template and observed that iHMSC cells recovered from
cast hydrogels (obtained 1 h post casting with Alginate using
de-crosslinking methods from [18] ) were not different from no-
structure controls; demonstrating the complete process is bio-
compatible (Fig. S8). We repeated experiments with more sensi-
tive cell-types and found that human induced pluripotent stem
cells (HiPSCs), embryonic stem cells (HESCs), primary mesenchy-
mal stem cells (HMSCs) and umbilical vein endothelial cells (HU-
VECs) can also tolerate the process with no effect on viability (Fig.
S8) again suggesting no osmotic challenge to cells. 
3.5. Cell-laden vessel wall engineering by addition of crosslinkers to 
GSM 
In order to more fully recapitulate a completely vascularized
tissue, the lumen provided by the sacrificial material (providing
a source and sink for soluble molecules) also must be lined with
mass-transport regulating endothelial cells. These cells control in-
put and output from the lumen to the interstitial cells between
vessels. Initially we proved that vessel structures were indeed
linked and perfusable using laminar (rocking at 10 rpm) or pul-
satile (peristaltic pump) using flow of dye-spiked media (as shown
in Fig. S3). To create vessel walls lined with cells we developed
two approaches; one was to seed cells under flow by resuspending
in the perfusate as previously described [19] . The other approach
was developed by the addition of an ionic crosslinker to the GSM
formulation (which was not removed during PCL dissolution with
chloroform) allowing Alginate crosslinking directly onto the GSM
surface ( Fig. 2 ) [18] . During formulation we found that addition
of CaCl 2 or BaCl 2 crosslinkers ( > 1M or 100mM final concentra-
tion, respectively) stiffened the material and made the dried mate-
rial more brittle and fragile mechanically. However, using tailored
BaCl 2 concentrations (10-100mM), no effect on GSM mechanical
properties was observed and this allowed us to control crosslinking
distance from the GSM source. Furthermore, these concentrations
of BaCl 2 for the limited cross-linking time, has no effect on cell
viability (Fig. S1B). This approach has several advantages and tech-
nical implications. Directly crosslinking hydrogels to the surface of
the material and tailoring the matrix (Alginate) and crosslinker for-
mulation/concentration allowed ‘vessel walls’ to be created. These
walls could be 20μm to several millimetres thick as the crosslink-
ing distance was directly proportional to BaCl 2 concentration dif-
fusing from the GSM ( Fig. 2 A–D). Addition of cells to the matrix
during crosslinking allowed endothelial cells (HUVECs) to be cap-
tured specifically in the vessel wall and allowed a secondary ma-
trix or cell-type to be applied to form the bulk interstitial tissue
(here demonstrated for collagen; Fig. 2 E–G). Furthermore, as in
other studies, it was possible to seed endothelial cells on the inside
walls of lumen by slow perfusion if a cell adherent hydrogel was
used (such as collagen). In co-cultures with iHMSC cells labelled
with eGFP in the interstitial space ( Fig. 2 F, iHMSCs-GFP cells), en-
dothelial cells ( Fig. 2 E, HUVEC-mRFP cells, labelled with mRFP1)
could be fabricated first to line the original vessel structure. Impor-
tantly, we also demonstrate that the presence of endothelial cells
in vessel linings slows diffusion from vessels into the interstitial
scaffold creating a functional biological barrier (Fig. S9). This is ev-dence that the structures can be endothelialized employing our
ethods. 
.6. Metabolically dense tissues using GSM vascularization 
The major goal of a vascularization technology is to facilitate
he generation of dense cell-populated engineered matrices with-
ut generating necrotic areas due to poor mass transport. There-
ore, cellular function must be preserved when the conditions are
etabolically restrictive as seen in physiologically dense tissues.
ost physiological tissues have high cell densities, such as human
iver being ~6.5-18.5 × 10 7 cells/ gram of tissue [33] . Therefore we
ssessed the ability of our system to support cell biology at sim-
lar initial densities (up to 5 × 10 7 cells/ml hydrogel). We used
SM vascular sheets to assess construct metabolism as this al-
owed a simple visualization of the cells within constructs ( Fig. 3 ).
e loaded HEK293T cells (5 × 10 7 /ml) within GelMA matrices,
erfused them with pulsatile flow and were able to show that af-
er several days culture (up to day 3) that cells were uniformly
istributed but were only metabolically active close to the gel sur-
ace by Calcein-AM staining positivity ( Fig. 3 A and B). Importantly
e sectioned gels before staining to allow more uniform pene-
ration of the labelling. GSM-produced vessels showed increased
etabolism in the core which was highly localized around the ves-
el and at media exposed interfaces. Without perfusion neither
ontrol nor vascularized matrices had metabolic activity beyond
he gel perimeter. 
We employed two non-invasive assays for assessing longer-term
etabolism [24] within the entire engineered constructs. These
mployed either colorimetric assays based on resazurin reduc-
ion (PrestoBlue®; Fig. 3 C) over 7 days culture of HEK293T cells
5 × 10 7 /ml) or analysed secreted IgH export signal-mRFP fluo-
escent reporter directly from HepG2 hepatocytes (5 × 10 7 /ml)
 Fig. 3 D and E) [34] . Importantly we showed that, in densely popu-
ated gels, vascularization maintained cellular metabolism ( Fig. 3 C)
nd cellular secretion was enhanced ( Fig. 3 D and E). Although
hese experiments do not account for diffusion of resazurin, as
enetration of reagent or release of IgH-mRFP that is directly con-
rolled by construct porosity as well as cell metabolism, we were
ble to show that at high cell densities of two cell lines (which go
eyond the metabolism sustained by simple diffusion) that con-
tructs could overcome diffusion limits by addition of vessels, and
his is further promoted by perfusion ( Fig. 3 E). We also assessed
lbumin and Urea secretion (day 3 post-fabrication) from HepG2-
aden constructs fabricated with different densities of vasculariza-
ion (incorporating different numbers of vascular layers). These
nalyses showed that vascularized constructs with increased ves-
el layer densities produced more Albumin and Urea per cell than
f non-vascularized ( Fig. 3 F and G, respectively). 
Ideally neovascularization (or anastomosis) would be supported
f the vessels remained stable and could be remodelled over time
35] . It was clear that vessels retained integrity throughout the 7
ay culture period by macroscopic analyses. These data demon-
trate that cell metabolism and protein secretion is supported by
SM vasculature. Cell densities at or near to physiological values
an be achieved by this vasculature and subsequent perfusion il-
ustrating the value of GSM for engineering tissues. 
.7. Human-scale vascularized tissue constructed using GSM 
To fully demonstrate the utility of the system, we 3D printed a
hannel-containing human nose ( Fig. 4 ) derived from a CT scan of
 patient ( Fig. 4 A). We infilled the PCL pores ( Fig. 4 B) with GSM
nd removed the PCL by chloroform ( Fig. 4 C). The structure re-
ained intact and mirrored the initial PCL scaffold and CT scan.
he structure was then infilled with Alginate (1% w/v) containing
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Fig. 2. Cell loaded vessel walls and interstitial spaces using GSM. ( A) Schematic of crosslinker diffusion from GSM to create hydrogel-coated vessel walls. Increasing amounts 
of crosslinker creates a thicker vessel wall upon exposure to Alginate (50mM versus 500 mM BaCl 2 ). Bar is 750μm. ( B) BaCl 2 -mediated crosslinking of Alginate can create a 
range of wall thicknesses (80–600μm). CaCl 2 -mediated crosslinking requires higher concentrations for crosslinking and cannot generate as thin vessel walls. ( C) Vessel wall 
thickness is affected by Alginate concentration but is tuneable using BaCl 2 crosslinking. ( D) PLGA-coating of GSM structures before hydrogel encapsulation creates thinner 
vessel walls (~40μm). Vessel walls were measured by microscopy and calculating thickness using a scale calibration. ( E–G) Vascularized constructs containing endothelial 
































HMSC-GFP cells (1 × 10 7 /ml) yielding a vascularized and cellu-
arized human nose construct ( Fig. 4 D). The vessels could be per-
used with fluorescent dye TMR (By injecting into the centre of the
caffold with a syringe) and the cells imaged within the construct
 Fig. 4 E and F). To examine viability, we cultured constructs in ro-
ating culture (20rpm) and compared the survival by metabolism
f the nose construct compared to the same shape and volume
onstruct without vessels (by injection moulding of Alginate). The
ascularized construct possessed higher initial metabolism and re-
ained obvious activity over a 14 day period in a rotating cul-
ure, whereas the bulk nose rapidly lost cell metabolism and re-
ained only minimal viability at the construct surface ( Fig. 4 G).
ascularized noses increased in cell metabolism with a decrease
lightly below starting levels over a 7 day period which is likely
o be improved by using alternative hydrogels to Alginate and also
e a function of the proliferation status and not simply viability.vascular constructs did not increase metabolism whatsoever high-
ighting the need of vessels to support cells in such large struc-
ures. To further understand this loss of metabolism we assessed
he cell number and viability of cells at day 14, by decrosslink-
ng the Alginate hydrogel and digesting cells with collagenase. Im-
ortantly, 78 ±9% compared to 21 ±11% cell viability in vascular-
zed verses non-vascularized hydrogels was observed ( n = 3). Fur-
hermore, we confirmed 5.7 ±2.4 × 10 7 compared to 1.6 ±0.9 × 10 6 
iable cells/ml in vascularized and non-vascularized, respectively.
s the starting cell density was 1 × 10 7 /ml this shows a ~5-
old expansion and ~6-fold loss of viable cell numbers, with and
ithout vascularization, respectively. We therefore confirm viabil-
ty and expansion of ihMSCs in these structures, with metabolism
ecreasing likely to be a function of cell density and prolifera-
ion/differentiation status. 
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Fig. 3. GSM-mediated vascularization promotes cell viability and functionality. (A) Schematic of the constructs created to test avascular versus vascularized GelMA hydrogels. 
( B) HEK293T cells (5 × 10 7 cells/ 1ml construct) were generated with and without vasculature and cultured. Constructs were sectioned at day 3 (at the plane shown in A) 
and stained for live cells using Calcein-AM. Brightfield and fluorescent images are shown. Metabolically active live cells appear at the media/hydrogel interfaces including 
those formed by vessels. Bar is 500 μm. ( C) Constructs loaded with HEK293T cells (5 × 10 7 cells/ 1ml construct) were examined without manipulation using PrestoBlue 
metabolic assay over a 7 day time course. Metabolic activity was ratioed to avascular construct metabolism at time point 0 (denoted as 100%). Initial metabolic activity 
is higher in the vascular constructs as they promote diffusion of the assay reagent and produce a more efficient reaction condition. Vascularized constructs increase 
metabolism with a decrease slightly below starting levels over the 7 day period. Avascular constructs did not increase metabolism over the experiment and finished at 22.5% 
of the starting metabolism after the 7 days. ( D) Constructs loaded with HepG2 hepatocytes (5 × 10 7 cells/ml) were created with different layers of vessels (in the same 
hydrogel volume per layer, 100μl, 1 × 10 × 10mm; depth x width x length, respectively). We used IgH-tagged mRFP expressing HepG2 cells which secrete red fluorescence 
into the culture media and therefore can be used to non-invasively assess cell metabolism and mimic growth factor secretion. The more vessels the more significant the 
IgH-mRFP secretion, increasing layers of non-vascularized hydrogel did not significant increase the amounts of IgH-mRFP produced (assayed at day 3 post-fabrication) ( n = 3). 
IgH-mRFP relative fluorescence units (RFU) are normalized to solid, one layer samples. ( E) Constructs were created with different quantities of cells (0-5 × 10 7 cells/ml, with 
each construct layer requiring 100μl volume) with or without vascular structures. Vascularized constructs shown significantly more IgH-mRFP secreted at all densities over 
non-vascularized. Also vascularized constructs were able to support enhanced secretion at high cell densities than non-vascularized constructs ( n = 3). IgH-mRFP relative 
fluorescence units (RFU) are normalized to solid, 1 × 10 7 HepG2 cell samples. ( F,G) The sample constructs as described in ( D) were assessed for secretion of F) Albumin 
and ( G) Urea at day 3 (post-fabrication). Vascularized constructs with increased numbers of layers of vascular structures produced more albumin and urea per cell than if 
non-vascularized ( n = 3). ∗ p < 0.05. 
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Fig. 4. GSM-mediated vascularization of a human-scale nose constructs. (A) Computer-aided design projection created from a CT scan of a human nose. ( B) 3D printed 
porous nose using PCL as an initial scaffold structure. Graph paper is 1mm 2 /square. ( C) GSM filled nose with PCL removed using chloroform solubilization. ( D) Alginate filled 
nose with GSM removed by incubation in phenol-red free growth media at 37 °C for 3 h (120rpm mixing). GSM and Alginate were injected into the PCL and GSM structures, 
respectively using an air driven syringe. ( E,F) Microscopy of a section of the nose Alginate constructs (containing 1 × 10 7 /ml iHMSC-GFP cells) showing ( E) light microscopy 
of the vessels created by the sacrificial GSM, and (F) vessels shown by injection of TMR (fluorescent red) label and interstitial Alginate hydrogel containing iHMSC-GFP 
cells (fluorescent green) signal. Bar is 500 μm. ( G) Equivalent non-vascularized and GSM-vascularized nose constructs were examined without manipulation using PrestoBlue 
metabolic assay over a 14-day time course. Metabolic activity was ratioed to avascular nose construct metabolism at time point 0 (denoted as 100%). Initial metabolic activity 
is higher in the vascular constructs as they promote diffusion of the assay reagent and produce a more efficient reaction condition. Vascularized noses increase metabolism 
with a decrease slightly below starting levels over the 7 day period. Avascular constructs did not increase metabolism over the experiment ( n = 3). 


















































































































Most previous studies aiming to produce engineered tissue-
like vasculature have employed layer-by-layer stacking of individ-
ually fabricated sheets. A technological improvement for the fab-
rication of such structures was achieved by employing 3D printed
carbohydrate-dextran lattices as a sacrificial material to allow en-
tire networks to be monolithically cast inside matrices to create
tissue-like vessels in one step [5] . Building on this approach, we
were able to create a temperature-sensitive, inexpensive sugar-
based material that could be used in additive manufacturing and
casting techniques to create stable and well-defined vascular net-
works theoretically for any 3D printable design and at human
sizes. The developed GSM material has been tailored for its ease of
application and flowability making it ideal for these applications.
GSM can also be sterilized in pure chloroform further facilitating
translation of its use. A denser material would be less flowable
but create a more rigid material and allow higher resolution and
accuracy. A less dense material would be easy to manipulate and
flowable but not allow fine detail, intricate or accurate patterning.
The formulation of GSM allows sufficient density and flowability to
achieve both aims. We have demonstrated that GSM can be used to
pre-fabricate vascular patterns (by moulding) or directly fabricate
vascular patterns on prefabricated materials (PCL) without com-
promising biocompatibility and can be used with a wide variety
of cells and tissue/matrix applications. Ideally such systems would
support the process of anastomosis (cross connectivity by neovasu-
larization) during tissue development post-fabrication. We believe
that our 3D printed vascular constructs would support hydrogel re-
modelling by loaded cells (such as HUVECs) and differentiation us-
ing the suitable angiogenic factors (such VEGF). Employing hydro-
gels such as GelMA or fibrin could create the optimal mechanical
properties sufficient for anastomosis and facilitate long-term con-
tinuous perfusion of already established networks [35] . 
Our material has significant benefits over using the previously
described carbohydrate-dextran glass technologies [5] . GSM can be
used on conventional 3D printers and can use PCL as a mould
or scaffold during manufacturing to generate more mechanically
strong constructs which can be used with slower crosslinking hy-
drogels. GSM does not confer mechanical properties to the re-
sultant scaffolds, which is a function of the hydrogels and other
materials. Also scaffold mechanics is linked to the development
of tissue from progressive cell proliferation and ECM deposition.
The material properties can be fine-tuned with simple change of
humidity or temperature, converting a dry brittle material to an
elastic, mouldable putty. No complex fabrication is required as for
the ‘drawing’-based printing process used for carbohydrate-dextran
glass [5] ; this is because PCL is thermally extruded and GSM can
then be either extruded or cast within the PCL structure. This at-
tribute allows complex STL files (converted from patient CT scans)
to be directly printed. We demonstrated this by printing vascula-
ture within a human nose designed from a CT scan ( Fig. 4 ). Impor-
tantly, GSM is temperature-sensitive meaning that PLGA-coating
(as for carbohydrate-dextran glass) is not required to improve me-
chanical integrity during matrix casting. GSM is simply flowed out
of the vessels post-matrix crosslinking by increasing the ambient
temperature > 37 ̊C; importantly this allows slow setting hydrogels
such as collagen type-I and Matrigel TM to be used with the system.
Unlike layer-by-layer processes, engineered constructs are vascu-
larized in minutes and can be perfused directly post-evacuation
of the GSM. Further modifications of GSM could allow more con-
trol over vessel circularity and surface smoothness and making
GSM completely self-supporting without gelation. However, the at-
tributes demonstrated allow precise control of vessel diameter and
unlimited 3D architectural fabrication, meaning this technique is
valuable in biofabrication effort s. Our material may now be usedo aid human-scale tissue engineering effort s and create trans-
lantable materials with significant vascular transport to prevent
issue necrosis and promote native physiological function. 
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